PLAU antibody
Quick Overview for PLAU antibody (ABIN7117556)
Target
See all PLAU AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- PLAU antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- plasminogen activator, urokinase
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:1000, IHC:1:20-1:200,IF: 1:20-1:200, IP: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Alternative Name
- PLAU
-
Background
-
Synonyms: Urokinase-type plasminogen activator (U-plasminogen activator, uPA)|Urokinase-type plasminogen activator long chain A|Urokinase-type plasminogen activator short chain A|Urokinase-type plasminogen activator chain B|PLAU
Background: PLAU(Urokinase-type plasminogen activator) is also named as uPA and belongs to the peptidase S1 family.UPA initiates a proteolytic cascade, which degrades extracellular matrix during tissue growth and remodelling.The secreted proform of UPA is activated after binding to a specific high affinity cell surface receptor. Secreted UPA is exposed to rapid inactivation in the pericellular space by plasminogen activator inhibitor-1(PAI-1), which is stored in the extracellular matrix bound to vitronectin(PMID:9665342).It has 2 isoforms produced by alternative splicing.Defects in PLAU are the cause of Quebec platelet disorder(QPD).
-
Molecular Weight
- 54 kDa
-
Gene ID
- 5328
-
UniProt
- P00749
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration
Target
-